JCO-话题@MedSci

#JCO#

724篇内容 | 6948人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1891567, encodeId=d51a189156e39, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：曲妥珠单抗联合多西紫杉醇治疗晚期涎腺导管癌, objectType=article, longId=154708, objectId=3432154e08da, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3432154e08da, replyNumber=0, likeNumber=56, createdTime=2019-10-26, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3432154e08da, moduleTitle=JCO：曲妥珠单抗联合多西紫杉醇治疗晚期涎腺导管癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3432154e08da)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891584, encodeId=1da01891584ce, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：结直肠癌，肺癌和乳腺癌老年幸存者中阿片类药物使用的趋势, objectType=article, longId=161548, objectId=42b0161548b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=42b0161548b8, replyNumber=0, likeNumber=63, createdTime=2019-03-23, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=42b0161548b8, moduleTitle=JCO：结直肠癌，肺癌和乳腺癌老年幸存者中阿片类药物使用的趋势, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=42b0161548b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891554, encodeId=d0961891554ff, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：Dabrafenib联合Trametinib对BRAFV600突变Ⅲ期黑色素瘤患者无复发生存有益, objectType=article, longId=152422, objectId=77eb15242261, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=77eb15242261, replyNumber=0, likeNumber=79, createdTime=2019-04-04, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=77eb15242261, moduleTitle=JCO：Dabrafenib联合Trametinib对BRAFV600突变Ⅲ期黑色素瘤患者无复发生存有益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=77eb15242261)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891596, encodeId=b66518915964d, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：Interfant-06研究治疗1岁以下婴儿急性淋巴细胞白血病结果披露, objectType=article, longId=175431, objectId=a3cf1e5431c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a3cf1e5431c3, replyNumber=0, likeNumber=72, createdTime=2019-09-27, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a3cf1e5431c3, moduleTitle=JCO：Interfant-06研究治疗1岁以下婴儿急性淋巴细胞白血病结果披露, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a3cf1e5431c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891571, encodeId=512e18915e1bb, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：种族对转移性趋势抵抗前列腺癌患者总生存的影响优, objectType=article, longId=156476, objectId=70381564e646, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=70381564e646, replyNumber=0, likeNumber=58, createdTime=2019-09-12, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=70381564e646, moduleTitle=JCO：种族对转移性趋势抵抗前列腺癌患者总生存的影响优, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=70381564e646)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891599, encodeId=6cd2189159925, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：PD-L1用于新诊断的晚期经典霍奇金淋巴瘤, objectType=article, longId=177428, objectId=30a21e7428a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=30a21e7428a5, replyNumber=0, likeNumber=80, createdTime=2020-01-19, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=30a21e7428a5, moduleTitle=JCO：PD-L1用于新诊断的晚期经典霍奇金淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=30a21e7428a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891601, encodeId=fcd6189160109, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：癌王治疗现转机，胰腺癌治疗OS能翻倍, objectType=article, longId=178052, objectId=84dc1e8052f2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=84dc1e8052f2, replyNumber=0, likeNumber=65, createdTime=2019-09-01, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=84dc1e8052f2, moduleTitle=JCO：癌王治疗现转机，胰腺癌治疗OS能翻倍, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=84dc1e8052f2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891600, encodeId=56641891600f6, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：吉西他滨 - 艾日布林组合治疗转移性尿路上皮癌患者：最终报告（NCI-9653）, objectType=article, longId=177452, objectId=7d2e1e7452d0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7d2e1e7452d0, replyNumber=0, likeNumber=73, createdTime=2019-09-02, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7d2e1e7452d0, moduleTitle=JCO：吉西他滨 - 艾日布林组合治疗转移性尿路上皮癌患者：最终报告（NCI-9653）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7d2e1e7452d0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891592, encodeId=8500189159222, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：畸胎瘤对晚期生殖细胞肿瘤患者死亡率的影响, objectType=article, longId=172194, objectId=95561e21940e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=95561e21940e, replyNumber=0, likeNumber=0, createdTime=2020-05-27, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=95561e21940e, moduleTitle=JCO：畸胎瘤对晚期生殖细胞肿瘤患者死亡率的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=95561e21940e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891547, encodeId=e7cd189154e46, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：癌症化疗引起认知障碍, objectType=article, longId=149407, objectId=8b4714940e54, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8b4714940e54, replyNumber=0, likeNumber=84, createdTime=2019-04-29, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8b4714940e54, moduleTitle=JCO：癌症化疗引起认知障碍, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8b4714940e54)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891550, encodeId=3e32189155028, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：Teliso-V治疗实体瘤的首次人体研究, objectType=article, longId=150451, objectId=76c01504510f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=76c01504510f, replyNumber=0, likeNumber=84, createdTime=2019-02-24, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=76c01504510f, moduleTitle=JCO：Teliso-V治疗实体瘤的首次人体研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=76c01504510f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891560, encodeId=dded189156036, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：治疗相关心脏毒性及其对儿童患者预后的影响, objectType=article, longId=153088, objectId=7e7f15308864, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7e7f15308864, replyNumber=0, likeNumber=64, createdTime=2019-01-13, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7e7f15308864, moduleTitle=JCO：治疗相关心脏毒性及其对儿童患者预后的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7e7f15308864)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891544, encodeId=5de0189154487, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：一个基于血清的生物标志物谱，有望筛查早期胰腺癌, objectType=article, longId=148230, objectId=3527148230e2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3527148230e2, replyNumber=0, likeNumber=72, createdTime=2019-01-07, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3527148230e2, moduleTitle=JCO：一个基于血清的生物标志物谱，有望筛查早期胰腺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3527148230e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891565, encodeId=2f17189156554, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：肌层浸润膀胱癌的两种治疗方案比较, objectType=article, longId=154694, objectId=e43515469404, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e43515469404, replyNumber=0, likeNumber=66, createdTime=2019-10-17, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e43515469404, moduleTitle=JCO：肌层浸润膀胱癌的两种治疗方案比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e43515469404)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891569, encodeId=ce671891569aa, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：HIV感染对肝癌预后的影响, objectType=article, longId=156248, objectId=372f156248ee, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=372f156248ee, replyNumber=0, likeNumber=124, createdTime=2019-05-05, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=372f156248ee, moduleTitle=JCO：HIV感染对肝癌预后的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=372f156248ee)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891576, encodeId=d3a818915e691, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：来那度胺和阿扎胞苷组合：干细胞移植后急性髓细胞白血病复发患者的新型抢救疗法, objectType=article, longId=158465, objectId=a47115846533, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a47115846533, replyNumber=0, likeNumber=61, createdTime=2019-08-15, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a47115846533, moduleTitle=JCO：来那度胺和阿扎胞苷组合：干细胞移植后急性髓细胞白血病复发患者的新型抢救疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a47115846533)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891573, encodeId=606d18915e3c1, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：地塞瑞克与曲普瑞林治疗局部晚期内分泌反应性乳腺癌：随机II期试验, objectType=article, longId=157059, objectId=a02715e05966, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a02715e05966, replyNumber=0, likeNumber=75, createdTime=2019-05-22, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a02715e05966, moduleTitle=JCO：地塞瑞克与曲普瑞林治疗局部晚期内分泌反应性乳腺癌：随机II期试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a02715e05966)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891575, encodeId=0bf518915e58b, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：PARP抑制剂veliparib进军广泛期小细胞肺癌一线，小细胞肺癌又多了一种治疗方式？, objectType=article, longId=157547, objectId=091815e54770, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=091815e54770, replyNumber=0, likeNumber=67, createdTime=2019-12-10, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=091815e54770, moduleTitle=JCO：PARP抑制剂veliparib进军广泛期小细胞肺癌一线，小细胞肺癌又多了一种治疗方式？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=091815e54770)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891557, encodeId=2cbb189155e05, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：PET检测转移性精原细胞瘤化疗后残存肿瘤病灶的价值, objectType=article, longId=152445, objectId=68fc15244500, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=68fc15244500, replyNumber=0, likeNumber=71, createdTime=2019-03-25, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=68fc15244500, moduleTitle=JCO：PET检测转移性精原细胞瘤化疗后残存肿瘤病灶的价值, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=68fc15244500)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891579, encodeId=3f1218915e961, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：MET扩增是EGFR受体突变非小细胞肺癌患者TKI耐药的关键因素, objectType=article, longId=159074, objectId=2e171590e4ea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2e171590e4ea, replyNumber=0, likeNumber=70, createdTime=2019-09-20, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2e171590e4ea, moduleTitle=JCO：MET扩增是EGFR受体突变非小细胞肺癌患者TKI耐药的关键因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2e171590e4ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

JCO

2020-05-29

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：曲妥珠单抗联合多西紫杉醇治疗晚期涎腺导管癌

2019-10-26

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：结直肠癌，肺癌和乳腺癌老年幸存者中阿片类药物使用的趋势

2019-03-23

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：Dabrafenib联合Trametinib对BRAFV600突变Ⅲ期黑色素瘤患者无复发生存有益

2019-04-04

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：Interfant-06研究治疗1岁以下婴儿急性淋巴细胞白血病结果披露

2019-09-27

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：种族对转移性趋势抵抗前列腺癌患者总生存的影响优

2019-09-12

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：PD-L1用于新诊断的晚期经典霍奇金淋巴瘤

2020-01-19

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：癌王治疗现转机，胰腺癌治疗OS能翻倍

2019-09-01

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：吉西他滨 - 艾日布林组合治疗转移性尿路上皮癌患者：最终报告（NCI-9653）

2019-09-02

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：畸胎瘤对晚期生殖细胞肿瘤患者死亡率的影响

2020-05-27

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：癌症化疗引起认知障碍

2019-04-29

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：Teliso-V治疗实体瘤的首次人体研究

2019-02-24

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：治疗相关心脏毒性及其对儿童患者预后的影响

2019-01-13

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：一个基于血清的生物标志物谱，有望筛查早期胰腺癌

2019-01-07

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：肌层浸润膀胱癌的两种治疗方案比较

2019-10-17

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：HIV感染对肝癌预后的影响

2019-05-05

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：来那度胺和阿扎胞苷组合：干细胞移植后急性髓细胞白血病复发患者的新型抢救疗法

2019-08-15

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：地塞瑞克与曲普瑞林治疗局部晚期内分泌反应性乳腺癌：随机II期试验

2019-05-22

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：PARP抑制剂veliparib进军广泛期小细胞肺癌一线，小细胞肺癌又多了一种治疗方式？

2019-12-10

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：PET检测转移性精原细胞瘤化疗后残存肿瘤病灶的价值

2019-03-25

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：MET扩增是EGFR受体突变非小细胞肺癌患者TKI耐药的关键因素

2019-09-20

科室
- - 订阅+
  - 更多科室
工具
服务